IRIS
CHIRICOZZI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.077
AS - Asia 868
EU - Europa 841
SA - Sud America 118
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 8.933
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.037
SG - Singapore 372
CN - Cina 220
RU - Federazione Russa 144
IT - Italia 132
BR - Brasile 104
DE - Germania 93
UA - Ucraina 84
FR - Francia 80
HK - Hong Kong 77
VN - Vietnam 67
SE - Svezia 57
IE - Irlanda 55
GB - Regno Unito 53
PL - Polonia 44
IN - India 35
CA - Canada 30
FI - Finlandia 29
NL - Olanda 25
JP - Giappone 23
KR - Corea 19
ES - Italia 11
AR - Argentina 10
BD - Bangladesh 9
TR - Turchia 8
MX - Messico 7
UZ - Uzbekistan 7
ZA - Sudafrica 7
AT - Austria 6
RO - Romania 6
CH - Svizzera 5
KG - Kirghizistan 5
LT - Lituania 5
MY - Malesia 5
MA - Marocco 4
PH - Filippine 4
AU - Australia 3
BE - Belgio 3
DZ - Algeria 3
EG - Egitto 3
EU - Europa 3
ID - Indonesia 3
CZ - Repubblica Ceca 2
GA - Gabon 2
GH - Ghana 2
HR - Croazia 2
IL - Israele 2
IQ - Iraq 2
OM - Oman 2
PK - Pakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GI - Gibilterra 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
PA - Panama 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TW - Taiwan 1
VE - Venezuela 1
Totale 8.933
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.027
Wilmington 1.735
Houston 1.514
Singapore 250
Fairfield 218
Ashburn 164
Chandler 145
Ann Arbor 126
Seattle 83
San Jose 79
Hong Kong 77
Cambridge 76
Jacksonville 68
Beijing 67
Dearborn 64
Dublin 54
New York 51
Medford 45
Kraków 37
The Dalles 37
Rome 36
Zhengzhou 36
Santa Clara 32
Ho Chi Minh City 24
Tokyo 23
Los Angeles 22
Lawrence 21
Council Bluffs 20
Dallas 18
Hanoi 18
Lauterbourg 18
Buffalo 17
Milan 15
Moscow 15
Munich 15
San Diego 15
São Paulo 14
Amsterdam 13
Menlo Park 12
Montreal 11
Norwalk 11
Redondo Beach 10
Shanghai 9
Helsinki 8
Palo Alto 8
Hefei 7
Nanjing 7
Poplar 7
Warsaw 7
Boardman 6
Brooklyn 6
Chennai 6
Chicago 6
Denver 6
Detroit 6
Dhaka 6
Frankfurt am Main 6
Johannesburg 6
Orem 6
Toronto 6
Columbus 5
Kunming 5
London 5
Mumbai 5
Phoenix 5
Engelhard 4
Fuzhou 4
Nanchang 4
Redwood City 4
Bari 3
Boston 3
Brussels 3
Elk Grove Village 3
Esslingen am Neckar 3
Fortaleza 3
Goiânia 3
Guangzhou 3
Ludhiana 3
Manchester 3
Mexico City 3
Newark 3
Paris 3
Philadelphia 3
Pune 3
Salt Lake City 3
San Antonio 3
Trieste 3
Turin 3
Verona 3
Vienna 3
Accra 2
Ankara 2
Araguari 2
Araçatuba 2
Atlanta 2
Auburn Hills 2
Basel 2
Bexley 2
Brno 2
Casablanca 2
Totale 7.576
Salva come PNG Salva come JPEG
Nome #
Efficacy and safety of infliximab in psoriatic patients over the age of 65 546
AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa 528
Apremilast for the treatment of psoriasis. 477
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study 473
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 453
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis 446
Role of IL-23 in the pathogenesis of psoriasis: A novel potential therapeutic target? 439
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 422
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 410
Quality-of-life impairment in hidradenitis suppurativa 407
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis 403
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 394
Immunologic biomarkers for clinical and therapeutic management of psoriasis 381
Small molecules and antibodies for the treatment of psoriasis: A patent review (2010–2015) 369
Serum Protein Profile Changes in Psoriatic Patients Undergoing Treatment With Infliximab 364
Tofacitinib for the treatment of moderate-to-severe psoriasis 350
Biomolecular index of therapeutic efficacy in psoriasis treated by anti-TNF alpha agents. 334
Characterization of comorbid conditions burdening hidradenitis suppurativa: a multicentric observational study 334
Assessement of disease severity and treatment effectiveness in hidradenitis suppurtiva 333
Etanercept biosimilar SB4 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry 332
Alexithymia affects patients with hidradenitis suppurativa 309
Dupilumab Treatment in Children Aged 6-11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study 115
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years 103
Anogenital involvement: Clinical sign of severity in hidradenitis suppurativa 90
Factors related to the onset and recurrence of flares in hidradenitis suppurativa patients treated with adalimumab 80
Apheresis in the treatment of recalcitrant atopic dermatitis: Case series and review of the literature 65
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study 61
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study 58
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real-world multicentre Italian study 56
Totale 9.132
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.689
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.689
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202153 0 0 0 0 0 0 0 0 0 0 43 10
2021/2022211 13 22 21 13 8 19 10 8 14 20 17 46
2022/2023323 27 29 15 49 29 66 24 18 36 3 13 14
2023/2024177 19 1 10 5 13 39 8 16 4 15 7 40
2024/2025614 23 133 65 66 14 41 73 30 35 55 55 24
2025/20261.089 94 50 141 153 106 30 149 148 113 98 7 0
Totale 9.132